Determination of paroxetine in geriatric depression by high-performance liquid chromatography

Pharmacological Research

Volumn 48, Issue 2, 2003, Pages 217-221

  Zainaghi, Isis A ^a   Lanchote, Vera L ^a   Queiroz, Regina H C ^a  

^a Department of Clinical   (Brazil)

Author keywords

Depressed geriatric patients; HPLC; Paroxetine

Indexed keywords

PAROXETINE;

ACCURACY; ARTICLE; DEPRESSION; DRUG ISOLATION; GERIATRIC DISORDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; ULTRAVIOLET RADIATION;

EID: 0038205749     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00098-7     Document Type: Article

References (25)

1. Holliday S.M., Plosker G.L. Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy. Drugs Aging. 3:1993;278-299.
2. Gottfries C.G., Karlsson I., Nyth A.-L. Treatment of depression in elderly patients with and without dementia disorders. Int. Clin. Psychopharmacol. 6(Suppl. 5):1992;354-359.
3. Lane R., Baldwin D., Preskom S. The SSRIs: advantages, disadvantages and differences. J. Psychopharmacol. 9(Suppl.):1995;5-11.
4. Goldberg R.J. Antidepressant use in the elderly. Drugs Aging. 11(2):1995;119-131.
5. Caccia S. Metabolism of the newer antidepressants. Clin. Pharmaccokinet. 34:1998;281-302.
6. Baumann P. Pharmacokinetic-pharmacodynamic relationship of selective serotonin reuptake inhibitors. Clin. Pharmacokinet. 31:1996;444-469.
7. Lundmark J., Bengtsson F., Nordin C., Reis M., Walinder J. Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients. Acta Psychiatr. Scand. 101:2000;354-359.
8. Linder M.W., Keck P.E. Jr. Standards of laboratory practice: antidepressants drug monitoring. Clin. Chem. 44(5):1998;1073-1084.
9. Preskorn S.H., Byrke M.J., Fast G. Therapeutic drug monitoring: principles and practice. Psychiatr. Clin. Am. 16(3):1993;611-645.
10. Preskorn S.H. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. Clin. Pharmacokinet. 32(1):1997;1-21.
11. Lucca A., Gentilini G., Lopez-Silva S., Soldarini A. Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography. Ther. Drug Monit. 22:2000;271-276.
12. Geretsegger G., Bohmer F., Ludwing M. Paroxetine in the elderly depressed patients: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects. Int. Clin. Psychopharmacol. 9:1994;25-29.
13. Benbow S.J., Gill G. Paroxetine hepatotoxicity. Brit. Med. J. 314:1997;1387.
14. Eap C.B., Bouchoux G., Amey M., Cochard N., Savary L., Baumann P. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. J. Chromatogr. Sci. 36:1998;365-371.
15. López-Calull C., Domingues N. Determination of paroxetine in plasma by high-performance liquid chromatography for bioequivalence studies. J. Chromatogr. B. 724:1999;393-398.
16. Eap C.B., Baumann P. Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients. J. Chromatogr. B. 686:1996;51-63.
17. Foglia J.P., Sorisio D., Krishner M., Pollock B.G. Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection. J. Chromatogr. B. 693:1997;147-151.
18. Brett M.A.et al. Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 419:1987;438-444.
19. Kristoffersen L., Bugge A., Lundanes E., SlØrdal L. Simultaneous determination of citalopram, fluoxetine, paroxetine, and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection. J. Chromatogr. B. 734:1999;229-246.
20. Härtter S., Hermes B., Szegedi A., Hiemke C. Automated determination of paroxetine and its main metabolite by column switching and on-line high-performance liquid chromatography. Ther. Drug Monit. 16:1994;400-406.
21. Shin J.-G., Kim K.-A., Yoon Y.-R., Cha I.-J., Kim Y.-H., Shim S.-G. Rapid simple high-performance liquid chromatography determination of paroxetine in human plasma. J. Chromatogr. B. 713:1998;452-456.
22. Tournel G., Houdret N., Hédouin V., Deveaux M., Gosset Lhermitte M. High-performance liquid chromatography method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J. Chromatog. B. 761:2001;147-158.
23. Lacassie E., Gaulier J.M., Marquet P., Rabatel J.F., Lachâtre G. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. J. Chromatogr. B. 742:2000;229-238.
24. Labat L., Deveaux M., Dallet P., Dubost J.P. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J. Chromatogr. B. 773:2002;17-23.
25. Bonato P.S., Lanchote V.L. A rapid procedure for the purification of biological samples to be analyzed by high-performance liquid chromatography. J. Liq. Chromatogr. 16:1993;2299-2308.